Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children …
HJ Sharma, S Parekh, P Pujari, S Shewale… - Expert Review of …, 2023 - Taylor & Francis
Background This study assessed safety and immunogenicity of Serum Institute of India Pvt
Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster …
Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
R Baxter, J Hansen, J Timbol, V Pool… - Human Vaccines & …, 2016 - Taylor & Francis
An observational post-licensure (Phase IV) retrospective large-database safety study was
conducted at Kaiser Permanente, a US integrated medical care organization, to assess the …
conducted at Kaiser Permanente, a US integrated medical care organization, to assess the …
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
C Sirivichayakul, P Chanthavanich… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT Background: An acellular Pertussis (aP) vaccine containing recombinant
genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and …
genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and …
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
[HTML][HTML] Adverse effects of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in 6-to 7-year-old children
SH Wei, YN Chao, SE Huang, TF Lee… - Pediatrics & Neonatology, 2011 - Elsevier
Although the safety profile of tetanus toxoid, reduced diphtheria toxoid, and acellular
pertussis (Tdap) vaccines in adolescents and adults has been documented, few data have …
pertussis (Tdap) vaccines in adolescents and adults has been documented, few data have …
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in …
NP Klein, J Hansen, E Lewis, L Lyon… - The Pediatric …, 2010 - journals.lww.com
Background: Prelicensure clinical studies may not include sufficient numbers of subjects to
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …
A 6-year prospective, observational, multi-center post-marketing surveillance of the safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …
HJ Park, SJ Kim, J Chen, JH Kim… - Journal of Korean …, 2019 - synapse.koreamed.org
Background Incidence of whooping cough is increasing in Korea. Since 2011, occurrence
among adolescents and adults has risen putting vulnerable neonates at risk. National …
among adolescents and adults has risen putting vulnerable neonates at risk. National …